‘Stribild’ unveiling its research for the first time stated “We will lead HIV treatment”

‘Stribild,’ which has opened the new era of single-tablet complex drugs in the HIV/AIDS treatment, has continuously expanded its position. Although relatively starting as a last mover, the product has been increased in frequency of selection with its interesting clinical study results to doctors.

Gilead Science’s ‘Stribild’ has announced a new beginning as a AIDS complex in the domestic market...